Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | -0.81% | 53.55 | 0.9% | $1397.05m | |
| JNJ | Johnson & Johnson | -0.02% | 179.43 | 0.7% | $1295.65m | |
| BMY | Bristol-Myers Squibb Co. | -2.36% | 75.76 | 1.0% | $1183.57m | |
| MRK | Merck & Co., Inc. | 0.05% | 92.36 | 0.7% | $1167.53m | |
| ABBV | AbbVie, Inc. | -1.23% | 148.72 | 1.9% | $1086.85m | |
| LLY | Eli Lilly & Co. | 1.66% | 318.66 | 1.1% | $983.26m | |
| AZN | AstraZeneca Plc | 0.80% | 67.24 | 1.0% | $495.48m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 0.19% | 143.45 | 0.0% | $493.51m | |
| NVS | Novartis AG | -0.12% | 91.15 | 0.2% | $259.53m | |
| GSK | GlaxoSmithKline Plc | -1.10% | 43.93 | 0.2% | $254.75m | |
| VERU | Veru, Inc. | -0.91% | 12.53 | 0.0% | $251.50m | |
| HZNP | Horizon Therapeutics Plc | 3.39% | 93.67 | 5.4% | $202.69m | |
| SGEN | Seagen Inc. | 3.06% | 142.69 | 5.7% | $191.34m | |
| NVO | Novo Nordisk A/S | 0.65% | 107.29 | 0.1% | $184.04m | |
| VTRS | Viatris, Inc. | 1.00% | 12.13 | 0.0% | $166.92m |
Company Profile
Repligen Corp. provides bioprocessing technologies and solutions used in the process of manufacturing biologic drugs. It serves through the following product lines: Chromatography, Filtration, Process Analytics, and Proteins. The Chromatography product includes a range of products used in the downstream purification and quality control of biological drugs. The Filtration products offer a number of advantages to manufacturers of biologic drugs at volumes that span from pilot studies to clinical and commercial-scale production. The Process Analytics products complement and support filtration, chromatography and proteins in-line absorbance measurements allowing for the determination of protein concentration in filtration, chromatography formulation and fill-finish applications. The Proteins product franchise is represented by Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification of virtually all mAb-based drugs on the market. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.